BRIEF-Hemispherx Biopharma received approval of its new drug application from ANMAT

viernes 26 de agosto de 2016 01:09 GYT
 

Aug 26 (Reuters) - Hemispherx Biopharma Inc

* Received approval of its new drug application from anmat for commercial sale of rintatolimod in argentine republic

* Product will be marketed by GP Pharm, Hemispherx's commercial partner in Latin America

* Will continue to seek approval in additional Latin American countries

Source text for Eikon:

Further company coverage: